Ariel Guo

Company: Antengene

Job title: CVP, Business Development & Assistant Chief Operating Officer

Seminars:

AnTenGager: Emerging Novel Second Generation TCE with Better Safety & Efficacy – Masking Technologies via Steric Hindrance 1:30 pm

DAA bivalent binding for deeper depletions of the targeT-Cells Steric hindrance-based masking and DAA- gated CD3+ T-Cell activation Novel CD3 DE/EG binder with fast on/fast off binding kineticsRead more

day: Day One